Jeffrey F. Eisenberg - 24 Mar 2022 Form 4 Insider Report for Xenetic Biosciences, Inc. (XBIO)

Role
Chief Executive Officer, Director
Signature
/s/ Jeffrey F. Eisenberg
Issuer symbol
XBIO
Transactions as of
24 Mar 2022
Net transactions value
$0
Form type
4
Filing time
28 Mar 2022, 17:16:48 UTC
Next filing
13 Dec 2023
SEC
View on sec.gov

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction XBIO Stock Options Award $0 +100,000 $0.000000 100,000 24 Mar 2022 Common Stock 100,000 $1.12 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares underlying the options will vest and become exercisable as follows: one-third of the shares shall vest on the first anniversary of March 24, 2022; the remaining two-thirds of the shares shall vest in eight equal quarterly installments commencing on June 24, 2023 and ending on March 24, 2025.